David A Burden

13PUBLICATIONS
58CO-AUTHORS
PharmacogenomicsCommunity psychologyToxicology (incl. clinical toxicology)AllergyPetrophysics and rock mechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

|Jun 07, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.

Jonathan N Barker, Gabrielle Becher, David A Burden

|Sep 21, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.

A David Burden, Robert Bissonnette, Alexander A Navarini

|May 04, 2023
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study.

A D Burden, Y Okubo, M Zheng

|Mar 24, 2023
Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis.

A David Burden

|Jan 21, 2022
Clinical Disease Measures in Generalized Pustular Psoriasis.

A David Burden, Siew Eng Choon, Alice B Gottlieb

Pageof 3

Frequent Collaborators

4 joint publications

Jonathan N Barker

4 joint publications

Christopher E M Griffiths

4 joint publications

Nick J Reynolds

3 joint publications

Catherine H Smith